• Most Popular
  • Most Shared

Israel's Teva gets FDA nod for generic version of Uniretic

Fri Mar 9, 2007 10:04am EST

Stocks

   

Regulatory News

March 9 (Reuters) - Teva Pharmaceutical Industries Ltd. (TEVA.O) said the U.S. Food and Drug Administration has approved its generic version of Schwarz Pharma's SRZG.DE Uniretic tablets, a treatment for hypertension.

In a news statement, Teva said shipment of the Moexipril HCl and Hydrochlorothiazide tablets will begin immediately.

(Reporting by Sweta Singh in Bangalore)

((Editing by Valerie Lee; Reuters messaging: sweta.singh.reuters.com@reuters.net; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800)) Keywords: TEVA FDA/

(C) Reuters 2007. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nWNAS3627
Regulatory News


More from Reuters

Photo

Obama blames "systemic failures" for plane attack

KANEOHE, Hawaii (Reuters) - President Barack Obama on Tuesday blamed "human and systemic failures" for allowing a botched Christmas Day attack aboard a Detroit-bound airliner and a U.S. official said the incident was linked to al Qaeda. | Video

» More Top News
A man passes by a logo of the Tokyo Stock Exchange at the bourse in Tokyo December 29, 2009. REUTERS/Yuriko Nakao

Toyko trade gets turbocharged

The "Arrowhead" gives Asia's largest -- and long derided -- bourse a viable electronic trading platform, it hopes.  Full Article 

Global Markets
REUTERS/James Saft
JAMES SAFT:

Welcome to the "Teenies"

Shrinking financial sector? Paltry investment returns? Welcome to the the next decade. Don't worry, there's some good news, too.  Commentary 

COMMENTARY